How to orchestrate cell & gene therapy supply chains

About a year and a half ago, we were asked by a client in the US to help them implement capacity planning & detailed scheduling for manufacturing and quality operations in a CAR-T cell & gene therapy production plant.

What are the insights that we have gained since then? And what have we discovered as game-changing elements in the end-to-end supply chain orchestration? You will discover it in Geert’s presentation.

Key takeaways

  • In this new market, demand is exploding but supply chain is immature
  • There’s a mind shift towards a new kind of supply chain, with a lot of moving parts
  • Need to be extremely agile and be able to react in real-time to volatilities in the supply chain

Watch now for free

Featured speakers

  • test
    Geert Vanhove
    Co-founder and Executive VP of Binocs

These resources might interest you

  • Industrializing the next generation of cell and gene therapies

    Watch our webinar to discover the game-changing elements of end-to-end cell and gene therapy supply chain orchestration.
    Download now
  • Scaling CGT supply chains: from clinical to commercial

    Watch our webinar to discover the game-changing elements of end-to-end cell and gene therapy supply chain orchestration.
    Download now
  • How to tackle manufacturing planning for cell and gene therapy?

    Watch our webinar to discover the game-changing elements of end-to-end cell and gene therapy supply chain orchestration.
    Read more